MLTX Stock Analysis: Buy, Sell, or Hold?
MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
$21.61
-0.55 (-2.48%)
▼
5d:
+12.61%
30d:
+17.0%
90d:
+28.1%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Accumulation
None View Scanner →
Strength: 4.8/10
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MLTX is 11.3% above its trading range ($19.42). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MLTX is 11.3% above its trading range ($19.42). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $21.61, which is considered extended relative to its 30-day fair value range of $17.27 to $19.42.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $17.00, while resistance sits at $23.29.
Market Sentiment: MLTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.62 (+24.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $17.00, while resistance sits at $23.29.
Market Sentiment: MLTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.62 (+24.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.27 -
$19.42
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
MLTX is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.6% below Wall St target ($27.62)
Trading Range Analysis
30-Day Trading Range
$17.27 -
$19.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.00
Resistance Level
$23.29
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.43
Wall Street Target
$27.62
(+24.6%)
Share & Embed Analysis
Last updated: June 23, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Da Silva Jorge Santos
SELL
51873 shares
2026-04-13
Da Silva Jorge Santos
SELL
98127 shares
2026-04-10
Bvf Partners L P/Il
SELL
3750000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.
